- ID: 1561811
- March 2016
- 2 pages
- Sheila Greco Associates
Masimo NASDAQ MASI is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve unsolvable problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry s ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin SpHb, oxygen content SpOC', carboxyhemoglobin SpCO, methemoglobin SpMet, and Pleth Variability Index PVI, in addition to SpO2, pulse rate, and perfusion index PI.
These individual Business Lists are 100% staff verified and details the company’s roster of key professionals and key decision makers.
- In addition to the executive contacts, this report contains:
- Global HQ Location
- US Address (Street, City, State & Zip)
- US HQ Phone Number & Company Website Address
- Most Recent
- Revenues Reported,
- Number of Employees and Industry.
These Business Lists do not include direct-dial phone numbers for all executives listed.
- This will provide the direct phone number.
- This report provides the HQ phone number and the accurate executive name and title.